US2002065407A1PendingUtilityA1
Molecular sequence of swine retrovirus and methods of use
Priority: Aug 18, 1998Filed: May 9, 2001Published: May 30, 2002
Est. expiryAug 18, 2018(expired)· nominal 20-yr term from priority
C07K 14/005C12N 2740/10022A61P 31/14A61K 2039/53A61K 39/00
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptides of the present invention are PERV-D env polypeptides. The invention also relates to detecting the presence of a porcine retrovirus in tissue comprising such polypeptides or polynucleotides that encode the polypeptides.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated polynucleotide, comprising:
a polynucleotide having at least 95% identity to a member selected from the group consisting of:
(a) a polynucleotide encoding a PERV-D polypeptide comprising amino acids 1 to 91 of SEQ ID NO: 2; and
(b) the complement of (a).
2 . The isolated polynucleotide of claim 1 , wherein said member is (a).
3 . A method of making a recombinant vector comprising inserting the isolated polynucleotide of claim 2 into a vector wherein the polynucleotide is DNA.
4 . A recombinant vector comprising the isolated polynucleotide of claim 2 , wherein the polynucleotide is DNA.
5 . A recombinant host cell comprising the isolated polynucleotide of claim 2 wherein said polynucleotide is DNA.
6 . The isolated polynucleotide of claim 2 comprising a polynucleotide encoding a polypeptide consisting of the amino acids 1 to 91 of SEQ ID NO: 2.
7 . A method for producing a polypeptide comprising expressing from the recombinant cell of claim 5 the polypeptide encoded by said polynucleotide.
8 . An isolated polypeptide comprising an amino acid sequence encoded by the isolated polynucleotide of claim 2 .
9 . The isolated polypeptide of claim 8 comprising amino acids 1 to 91 of SEQ ID NO:2.
10 . A method for detecting the presence of a porcine retrovirus in a tissue sample comprising detecting the presence of a polypeptide of claim 8 .
11 . An isolated polynucleotide, comprising:
a polynucleotide having at least 95% identity to a member selected from the group consisting of:
(a) a polynucleotide comprising the sequence shown as nucleotides 1-275 of SEQ ID NO: 1; and
(b) the complement of (a).
12 . The isolated polynucleotide of claim 11 , wherein said member is (a).
13 . A method of making a recombinant vector comprising inserting the isolated polynucleotide of claim 12 into a vector, wherein said polynucleotide is DNA.
14 . A recombinant vector comprising the isolated polynucleotide of claim 12 wherein said polynucleotide is DNA.
15 . A recombinant host cell comprising the isolated polynucleotide of claim 12 wherein said polynucleotide is DNA.
16 . The isolated polynucleotide of claim 12 comprising a polynucleotide consisting of the nucleotides 1-275 of SEQ ID NO: 1.
17 . A method for producing a polypeptide, comprising expressing from the recombinant cell of claim 15 the polypeptide encoded by said isolated polynucleotide.
18 . An isolated polypeptide comprising an amino acid sequence encoded by the polynucleotide of claim 12 .
19 . A method for detecting the presence of a porcine retrovirus in a tissue sample comprising detecting the presence of a polypeptide of claim 18 .
20 . An isolated polynucleotide, comprising at least 30 consecutive bases of a polynucleotide having the sequence shown as nucleotides 1-275 of SEQ ID NO: 1.
21 . An isolated polynucleotide of claim 20 , comprising at least 50 consecutive bases of a polynucleotide having the sequence shown as nucleotides 1-275 of SEQ ID NO:1.
22 . An isolated polynucleotide of claim 20 , comprising at least 75 consecutive bases of a polynucleotide having the sequence shown as nucleotides 1-275 of SEQ ID NO: 1.
23 . A method of making a recombinant vector comprising inserting the isolated polynucleotide of claim 20 into a vector.
24 . A recombinant vector comprising the isolated polynucleotide of claim 20 wherein said polynucleotide is DNA.
25 . A recombinant vector comprising the isolated polynucleotide of claim 21 wherein said polynucleotide is DNA.
26 . A recombinant host cell comprising the isolated polynucleotide of claim 20 wherein said polynucleotide is DNA.
27 . A recombinant host cell comprising the isolated polynucleotide of claim 22 wherein said polynucleotide is DNA.
28 . A method for producing a polypeptide, comprising expressing from the recombinant cell of claim 26 the polypeptide encoded by said polynucleotide.
29 . A method for producing a polypeptide, comprising expressing from the recombinant cell of claim 27 the polypeptide encoded by said polynucleotide.
30 . An isolated polypeptide comprising an amino acid sequence encoded by a polynucleotide of claim 20 .
31 . An isolated polypeptide comprising an amino acid sequence encoded by a polynucleotide of claim 21 .
32 . An isolated polypeptide, comprising an amino acid sequence encoded by a polynucleotide which is at least 95% identical to the isolated polynucleotide of claim 20 .
33 . An isolated polypeptide, comprising an amino acid sequence encoded by a polynucleotide which is at least 95% identical to the isolated polynucleotide of claim 21 .
34 . An isolated polypeptide, comprising an amino acid sequence encoded by a polynucleotide which is at least 95% identical to the isolated polynucleotide of claim 22 .
35 . An antibody against the polypeptide of claim 32 .
36 . An antibody against the polypeptide of claim 22 .
37 . A method for detecting the presence of a porcine retrovirus in a tissue sample comprising detecting the presence of a polypeptide of claim 32 .
38 . A method for creating passive immunity in a host comprising administering an effective amount of an antibody according to claim 35 .
39 . A method for creating passive immunity in a host comprising administering an effective amount of an antibody according to claim 36 .
40 . A vaccine for immunizing a host against a porcine retrovirus, comprising:
(a) administering an immunizing effective amount of a polypeptide of claim 8 ; or (b) administering an isolated polynucleotide of claim 2 , such that its encoded polypeptide is expressed in an immunizing effect amount.
41 . A vaccine for immunizing a host against a porcine retrovirus, comprising:
(a) administering an immunizing effective amount of a polypeptide of claim 18 ; or (b) administering an isolated polynucleotide of claim 12 , such that its encoded polypeptide is expressed in an immunizing effect amount.
42 . A vaccine for immunizing a host against a porcine retrovirus, comprising:
(a) administering an immunizing effective amount of a polypeptide of claim 30 ; or (b) administering an isolated polynucleotide of claim 20 , such that its encoded polypeptide is expressed in an immunizing effect amount.Join the waitlist — get patent alerts
Track US2002065407A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.